AI can generate words that sound like empathy, but it cannot offer the understanding that a real person can.
Michael Oleksiw
Advertisement
Michael Oleksiw is a corporate entrepreneur with over 20 years of experience developing innovative products and solutions. Throughout his diverse career, he has hand-crafted bicycles, commercialized software for clinical trials, launched groundbreaking CME technologies for doctors, and introduced leading fashion technology products to the world’s top brands. As CEO of Pleio, Michael has spent the last decade advancing frictionless, personalized solutions to support patients in their medication journeys. By addressing emotional barriers and minimizing medication non-adherence, Pleio delivers one of the most elegantly simple and effective adherence solutions in the pharmaceutical market.
Articles by Michael Oleksiw
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Lipfendra to reduce LDL-C in Adults with Hypercholesterolemia
2
Pharmaceutical Executive Daily: FDA Approves Lipfendra
3
Eli Lilly to Acquire AtaiBeckley for $2.8 Billion
4
The Power of Better Questions: How Great Leaders Balance Risk, Growth and Curiosity
5